Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Viventia options anticancer hybridomas from M.D. Cancer Center

Oct. 14, 2002

U. of Kentucky researchers present novel camptothecin prodrugs

Oct. 11, 2002

Protein kinase inhibitors described by Pharmacia as useful for cancer and other disorders

Oct. 11, 2002

OSI-211 enters phase II trials in ovarian and small cell lung cancers

Oct. 11, 2002

New program for TLK-286 in combination with chemotherapy

Oct. 10, 2002

GEM-231 reported to increase the antitumor efficacy of irinotecan

Oct. 10, 2002

First 20 sites open in phase III trial of Xyotax in NSCLC

Oct. 9, 2002

Novel prodrugs of antitumor compounds designed by academic researchers

Oct. 9, 2002

Roche researchers identify new HDAC inhibitors

Oct. 8, 2002

Synergistic antitumor effect for irofulven combined with mitomycin D or thiotepa

Oct. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...